YVONNE MATA: Open Payments
NPI 1649043498 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,326 in 144 payments from 18 companies in 2025. Trend: 2023 $15 · 2024 $231 · 2025 $4,326
Food & beverage: $4,326
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $629 |
| ABBVIE INC. | 36 | $587 |
| E.R. Squibb & Sons, L.L.C. | 9 | $541 |
| Janssen Pharmaceuticals, Inc | 8 | $444 |
| Alkermes, Inc. | 9 | $402 |
| Indivior Inc. | 9 | $341 |
| Vanda Pharmaceuticals Inc. | 11 | $323 |
| Otsuka America Pharmaceutical, Inc. | 4 | $275 |
| Corium, LLC | 7 | $198 |
| Almatica Pharma LLC | 6 | $144 |
Products named: CAPLYTA, VRAYLAR, COBENFY, SUBLOCADE, FANAPT, REXULTI, LYBALVI, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
